PELVIPHARM has a total of 19 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are SZEGOE PETER, SHIMA HIROKI and NEUMEDICINES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | France | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Electrotherapy | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Giuliano Francois | 15 |
#2 | Behr-Roussel Delphine | 6 |
#3 | Bernabe Jacques | 5 |
#4 | Borgdorff Aren | 5 |
#5 | Francois Giuliano | 2 |
#6 | Delphine Behr-Roussel | 2 |
#7 | François Giuliano | 1 |
#8 | Mac Kenna Kevin | 1 |
#9 | Delphine Behr Roussel | 1 |
#10 | Behr Roussel Delphine | 1 |
Publication | Filing date | Title |
---|---|---|
WO2009121921A1 | Method for restoring an ejaculatory failure | |
US2011009937A1 | Method for restoring an ejaculatory failure | |
EP2106792A1 | Use of a combination of udenafil and alfuzosin or oxybutynin for the treatment of overactive bladder | |
US2009018620A1 | Method for restoring an ejaculatory failure | |
FR2813193A1 | Medicine for the treatment of sexual dysfunctions by action on the central nervous system |